Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.
Saved in:
| Title: | Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults. |
|---|---|
| Authors: | Prasert K; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand., Nakphook S; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Kittiwatanachod J; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand., Sornwong K; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Naosri S; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Ongarj P; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand., Techatanawat I; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Narakorn P; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Surichan S; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Flores J; PATH, Seattle, WA 98103, USA., Mercer LD; PATH, Seattle, WA 98103, USA., Polyak CS; PATH, Seattle, WA 98103, USA., Innis BL; PATH, Seattle, WA 98103, USA., Raghunandan R; PATH, Seattle, WA 98103, USA., Pittayawonganon C; Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand., Iamsirithaworn S; Office of the Permanent Secretary, Ministry of Public Health, Nonthaburi 11000, Thailand., Sirilak S; Health Systems Research Institute, Nonthaburi 11000, Thailand., Wirachwong P; Government Pharmaceutical Organization (GPO), Bangkok 10400, Thailand., Praphasiri P; Nakhon Phanom Provincial Hospital, Nakhon Phanom 48000, Thailand.; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Campus, Kasetsart University, Sakon Nakhon 47000, Thailand. |
| Source: | Vaccines [Vaccines (Basel)] 2026 May 28; Vol. 14 (6). Date of Electronic Publication: 2026 May 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-393X |
|---|---|
| DOI: | 10.3390/vaccines14060481 |
